Call on pharmaceutical industry: work together against COVID-19

23 April 2020 | 1 min. readingtime

“Seek maximum collaboration”

Pharmaceutical companies around the world are doing everything they can to develop tests, a vaccine and medication to fight the coronavirus. As a committed shareholder, we, together with other parties, call on the pharmaceutical sector to pursue maximum collaboration in order to minimise the spread of the virus and its consequences worldwide. We call on them to seek maximum collaboration with each other, public authorities and research centres to that end, and not to allow themselves to be guided by short-term financial motives. That is the gist of our investor statement, which we are publishing together with close to 40 other national and international portfolio management companies, pension funds and insurance companies, with more than € 1,400 billion under management. Only together can we defeat the coronavirus.


Click the link below to read the investor statement (PDF).

  • Outlook
  • Sustainability


Raquel Criado Linkedin

Raquel Criado Larrea

Head of Sustainable Investments

Raquel is responsible for SRI policy and implementation at ASR Nederland.

Contact us